HCV infection: pathogenesis, clinical manifestations and therapy.
about
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosisInterstitial Lung Disease in Childhood: Clinical and Genetic AspectsHepatitis C virus infection and type 1 and type 2 diabetes mellitusAutoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infectionImmune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disordersViral arthritisAssociation of oral lichen planus with chronic C hepatitis. Review of the data in literature.Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cellsSerum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.Interstitial lung diseases in children.Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in taiwan.Peripheral B cells as reservoirs for persistent HCV infection.Cytokines and HCV-related disorders.Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminasesMixed cryoglobulinemia.Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.Environmental Issues in Thyroid DiseasesHepatitis C virus infection and its rheumatologic implications.Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.
P2860
Q26773278-A5838970-4F83-44C4-A19A-75909D30D193Q26778109-789E7249-4769-4852-8ED2-88A4E90A95ACQ26829202-B7AF378A-070B-4A1B-8E42-210ABE7C4FD5Q26830844-E7E5566F-9965-4850-9B6D-47B2447399A5Q27491280-24E3E531-0ACC-4C13-9993-B615DB10AE29Q28080121-BC779687-EAF5-4718-959E-13CDDB2A661BQ30882479-87BABE77-C3D1-4441-B4FB-D073B00C9CF1Q33664480-EE7348BE-AA0A-497B-B594-0DD3146B9D2BQ33839099-77BDD7DA-E231-4FD9-B819-03A0D92B7185Q34128163-AC1FE8EF-3787-41C3-A510-7A5056031866Q34557494-68A1DB26-D01C-4460-A340-81C67E3D926DQ35208308-09985B58-7640-4C5B-BB16-2C1D064660CFQ35960209-0353BC25-7C51-4D05-8233-E6878FD7CA49Q35964424-38502DF3-F6FE-4CAD-9FA6-EF3065D74B2FQ36942539-5F08BA2F-75AD-4066-8AE0-9040797DF048Q37345473-D5E3F65F-CD7D-4AD5-9CB4-6E27B51D03D2Q37710354-AD917A5E-B7AA-40D4-A41E-B5053F5EB682Q41560603-C83A1E94-DBFE-4C9A-97A5-87C1BCEAAD9AQ47171530-7E99F4B6-DE85-4DDC-A094-EE43ECD925F4
P2860
HCV infection: pathogenesis, clinical manifestations and therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HCV infection: pathogenesis, clinical manifestations and therapy.
@en
HCV infection: pathogenesis, clinical manifestations and therapy.
@nl
type
label
HCV infection: pathogenesis, clinical manifestations and therapy.
@en
HCV infection: pathogenesis, clinical manifestations and therapy.
@nl
prefLabel
HCV infection: pathogenesis, clinical manifestations and therapy.
@en
HCV infection: pathogenesis, clinical manifestations and therapy.
@nl
P2093
P1476
HCV infection: pathogenesis, clinical manifestations and therapy.
@en
P2093
A Antonelli
C Giannitti
D Roccatello
E Menegatti
G Mieli-Vergani
P304
P433
1 Suppl 48
P577
2008-01-01T00:00:00Z